Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick R Appelbaum

Showing results (151-160 of 339) with videos related to

Pageof 34
Sort By:
Haematologica|July 11, 2015
Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOGRoland B Walter, Megan Othus, Bob Löwenberg, et al.
Blood|January 8, 2005
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemiaJean E Sanders, Ho Joon Im, Paul A Hoffmeister, et al.
Blood Advances|July 25, 2020
Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter studyFilippo Milano, Jonathan A Gutman, H Joachim Deeg, et al.
Blood|May 13, 2004
Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011John C Byrd, Kanti Rai, Bercedis L Peterson, et al.
Blood|January 15, 2016
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantationMarco Mielcarek, Terry Furlong, Paul V O'Donnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2007
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantationMohamed L Sorror, Brenda M Sandmaier, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2016
Practice Patterns and Preferences Among Hematopoietic Cell Transplantation CliniciansWilliam A Wood, Margaret K McGinn, Doug Wilson, et al.
Blood|October 18, 2008
Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemiaPamela S Becker, Kenneth J Kopecky, Adrianne N Wilks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011Vicki A Morrison, Kanti R Rai, Bercedis L Peterson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2017
Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia PatientsOlga Sala Torra, Megan Othus, David W Williamson, et al.
Pageof 34

Showing results (151-160 of 339) with videos related to

Sort By:
Pageof 34
Haematologica|July 11, 2015
Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOGRoland B Walter, Megan Othus, Bob Löwenberg, et al.
Blood|January 8, 2005
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemiaJean E Sanders, Ho Joon Im, Paul A Hoffmeister, et al.
Blood Advances|July 25, 2020
Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter studyFilippo Milano, Jonathan A Gutman, H Joachim Deeg, et al.
Blood|May 13, 2004
Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011John C Byrd, Kanti Rai, Bercedis L Peterson, et al.
Blood|January 15, 2016
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantationMarco Mielcarek, Terry Furlong, Paul V O'Donnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2007
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantationMohamed L Sorror, Brenda M Sandmaier, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2016
Practice Patterns and Preferences Among Hematopoietic Cell Transplantation CliniciansWilliam A Wood, Margaret K McGinn, Doug Wilson, et al.
Blood|October 18, 2008
Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemiaPamela S Becker, Kenneth J Kopecky, Adrianne N Wilks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011Vicki A Morrison, Kanti R Rai, Bercedis L Peterson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2017
Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia PatientsOlga Sala Torra, Megan Othus, David W Williamson, et al.
Pageof 34